Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension
about
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectinN-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetesN-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure researchAc-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts.Thymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction.N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive ratsKinin B2 receptor is not involved in enalapril-induced apoptosis and regression of hypertrophy in spontaneously hypertensive rat aorta: possible role of B1 receptor.Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti-inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertensionN-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice.Therapeutic effect of mesenchymal stem cells on experimentally induced hypertensive cardiomyopathy in adult albino rats.Renal protective effect of N-acetyl-seryl-aspartyl-lysyl-proline in dahl salt-sensitive rats.Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in ratsCharacterization and localization of Ac-SDKP receptor binding sites using 125I-labeled Hpp-Aca-SDKP in rat cardiac fibroblastsPrevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosusCombination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after strokeThymosin beta4 and its posttranslational modifications.Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitorsPathophysiology of the aging kidney and therapeutic interventions.The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis.Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction.N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo.Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive miceProlyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.Ac-SDKP suppresses TNF-α-induced ICAM-1 expression in endothelial cells via inhibition of IκB kinase and NF-κB activation.Chimeric Adeno-Associated Virus-Mediated Cardiovascular Reprogramming for Ischemic Heart Disease.
P2860
Q24651908-A0D57145-B660-4F8A-9E71-881421BA2BE0Q27008887-A0BB0B45-AB40-40F2-94A8-38B74E33B332Q33604039-06B69CDD-4DF7-4997-9CD5-F192377EC37DQ33840689-99E04AE0-B3A5-4A2F-B95B-23AC2A51941EQ34296720-25D615AB-B74B-430B-8C34-3018DA60066AQ34554693-7A9D8AD7-C05C-447F-B3B9-F0FE91585410Q35046131-EC3914E8-FE6D-42FB-8739-568357579BB1Q35439583-B3199A02-72B4-4578-B46C-14EBB3A8BD2BQ35670580-6A5DC242-7040-478A-9042-A1EFB7F96132Q36174342-A5462A77-760C-42B9-B04F-91F4E1B5EEDDQ36234392-C13A696E-A8EC-405F-893E-588B7D541F19Q36315598-FB727759-A7E6-43AD-8077-0D427060E921Q36454235-1C053495-4F02-4CFE-95B0-689356DF64EBQ36513469-12C39CA0-0100-4F17-B6B3-11BF4173EB71Q36893345-6D1626D4-7FDA-404E-9933-C85224282B44Q37609039-2DB6099F-EE90-4FCB-994D-CBBD544927E8Q37666013-7A8900C9-6403-452E-B142-2601E949B93AQ37763967-EF2BC083-E465-45DA-A264-433DB6669F54Q37962590-5F0644BE-616B-41B4-B951-40D6DE4B549AQ38053074-2F9EB463-468C-42A7-AEEE-8805D3FB4A1BQ38224257-A565F621-3544-42F6-94E7-0A76D927FCBBQ40454979-60471C65-C441-4DBD-A4A4-B2B079744A53Q40535007-2C7EE4B7-46DA-46DE-9D72-73D11A7BB02AQ41549740-D5E88AD4-243C-43D0-9007-9994B25F9A05Q42158462-D7E16502-584F-46B2-9F0D-A11C1A822733Q42329928-D821DF66-4046-42A6-B668-E838FDE51D6CQ55691385-60584224-88C7-4A7B-8C9D-DCF28E1E810B
P2860
Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Long-term effect of N-acetyl-s ...... 2-kidney, 1-clip hypertension
@ast
Long-term effect of N-acetyl-s ...... 2-kidney, 1-clip hypertension
@en
Long-term effect of N-acetyl-s ...... 2-kidney, 1-clip hypertension
@nl
type
label
Long-term effect of N-acetyl-s ...... 2-kidney, 1-clip hypertension
@ast
Long-term effect of N-acetyl-s ...... 2-kidney, 1-clip hypertension
@en
Long-term effect of N-acetyl-s ...... 2-kidney, 1-clip hypertension
@nl
prefLabel
Long-term effect of N-acetyl-s ...... 2-kidney, 1-clip hypertension
@ast
Long-term effect of N-acetyl-s ...... 2-kidney, 1-clip hypertension
@en
Long-term effect of N-acetyl-s ...... 2-kidney, 1-clip hypertension
@nl
P2093
P2860
P1433
P1476
Long-term effect of N-acetyl-s ...... 2-kidney, 1-clip hypertension
@en
P2093
N E Rhaleb
O A Carretero
P2860
P304
P356
10.1161/01.CIR.103.25.3136
P407
P577
2001-06-26T00:00:00Z